Study of the phenotypic relationship in the IMR-32 human neuroblastoma cell line by sedimentation field flow fractionation

International Journal of Oncology

Volumn 31, Issue 4, 2007, Pages 883-892

  Begaud Grimaud G ^a   Battu, S ^a   Lazcoz, P ^b   Castresana, J S ^b   Jauberteau, M O ^a   Cardot, P J P ^a  

^a UNIVERSITY OF LIMOGES   (France)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Cell sorting; Cellular phenotype; Neuroblastoma cell line; Sedimentation field flow fractionation

Indexed keywords

BROXURIDINE; DIAGNOSTIC AGENT; NERVE CELL ADHESION MOLECULE L1; POLYSIALYL NEURAL CELL ADHESION MOLECULE; SIALIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL LINEAGE; CELL PROLIFERATION; FIELD FLOW FRACTIONATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; KINETICS; METABOLISM; NEUROBLASTOMA; PATHOLOGY; PHENOTYPE;

BROMODEOXYURIDINE; CELL ADHESION; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL LINEAGE; CELL PROLIFERATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; FRACTIONATION, FIELD FLOW; HUMANS; KINETICS; NEURAL CELL ADHESION MOLECULE L1; NEUROBLASTOMA; PHENOTYPE; SIALIC ACIDS; TUMOR CELLS, CULTURED;

EID: 35848936714     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.31.4.883     Document Type: Article

References (62)

1. Abemayor E and Sidell N: Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation. Environ Health Perspect 80: 3-15, 1989.
2. Morgenstern BZ, Krivoshik AP, Rodriguez V and Anderson PM: Wilms' tumor and neuroblastoma. Acta Paediatr Suppl 93: 78-85, 2004.
3. Brodeur GM, Seeger RC, Schwab M, Varmus HE and Bishop JM: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121-1124, 1984. (Pubitemid 14106392)
4. Schwab M, Ellison J, Busch M, Rosenau W, Varmus HE and Bishop JM: Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci USA 81: 4940-4944, 1984. (Pubitemid 14066230)
5. Berthold F, Hero B, Kremens B, et al: Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age. Cancer Lett 197: 11-17, 2003.
6. De Bernardi B, Nicolas B, Boni L, et al: Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma. J Clin Oncol 21: 1592-1601, 2003.
7. Hopkins-Donaldson S, Yan P, Bourloud KB, Muhlethaler A, Bodmer JL and Gross N: Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells. Oncogene 21: 6132-6137, 2002.
8. Voigt A, Hartmann P and Zintl F: Differentiation, proliferation and adhesion of human neuroblastoma cells after treatment with retinoic acid. Cell Adhes Commun 7: 423-440, 2000. (Pubitemid 30265258)
9. Cardot PJP, Battu S, Chianea T and Rasouli S: Cells and cell organelles: field-flow fractionation. In: Encyclopedia of Separation Science. Wilson ID, Adlard ER, Cooke M and Poole CF (eds). Academic Press, London, pp2267-2271, 2000.
10. Cardot PJP, Chianea T and Battu S: Sedimentation field flow fractionation of living cells. In: Encyclopedia of Chromatography. Cazes J (ed). M. Dekker Inc., New York, pp742-747, 2001.
11. Chianea T, Assidjo NE and Cardot PJP: Sedimentation field-flow- fractionation: emergence of a new cell separation methodology. Talanta 51: 835-847, 2000.
12. Bauer J: Advances in cell separation: recent developments in counterflow centrifugal elutriation and continuous flow cell separation. J Chromatogr B 722: 755-769, 1999.
13. Levin S: Field flow fractionation in biomedical analysis. Biomed Chromatogr 5: 133-137, 1991.
14. Wang XB, Yang J, Huang Y, Vykoukal J, Becker FF and Gascoyne PR: Cell separation by dielectrophoretic field-flow-fractionation. Anal Chem 72: 832-839, 2000.
15. Caldwell KD: Steric field-flow fractionation and steric transition. In: Field-Flow Fractionation Handbook. Schimpf ME, Caldwell KD and Giddings JC (eds). John Wiley & Sons, Inc., New York, pp 79-94, 2000.
16. Caldwell KD, Cheng ZQ, Hradecky P and Giddings JC: Separation of human and animal cells by steric field-flow fractionation. Cell Biophys 6: 233-251, 1984. (Pubitemid 15090066)
17. Caldwell KD, Nguyen TT, Murray TM, Myers MN and Giddings JC: Observations on anomalous retention in steric field-flow fractionation. Sep Sci Technol 14: 935-946, 1979.
18. Giddings JC: Field-flow fractionation: analysis of macromolecular, colloidal and particulate materials. Science 260: 1456-1465, 1993.
19. Giddings JC: The field-flow fractionation family: underlying principles. In: Field-Flow Fractionation Handbook. Schimpf ME, Caldwell K and Giddings JC (eds). John Wiley & Sons, Inc., New York, pp3-30, 2000.
20. Latham AH, Freitas RS, Schiffer P and Williams ME: Capillary magnetic field flow fractionation and analysis of magnetic nanoparticles. Abstracts of Papers, 230th ACS National Meeting, Washington, DC, 77: 5055-5062, 2005.
21. Martin M and Williams PS: Theoretical basis of field-flow fractionation. In: Theoretical Advancement in Chromatography and Related Separation Techniques. Dondi F and Guiochon G (eds). NATO ASI Ser., Ser. C: Mathematical and Physical Sciences. Kluwer, Dordrecht, pp513-580, 1992.
22. Plockova J, Matulik F and Chmelik J: Different elution modes and field programming in gravitational field-flow fractionation IV. Field programming achieved with channels of non-constant cross-sections. J Chromatogr A 955: 95-103, 2002. (Pubitemid 34311849)
23. Schure MR, Caldwell KD and Giddings JC: Theory of sedimentation hyperlayer field-flow fractionation. Anal Chem 58: 1509-1516, 1986. (Pubitemid 16585662)
24. Tong X and Caldwell KD: Separation and characterization of red blood cells with different membrane deformability using steric field-flow fractionation. J Chromatogr B 674: 39-47, 1995.
25. Williams PS, Lee S and Giddings JC: Characterization of hydrodynamic lift forces by field-flow fractionation. Inertial and near-wall lift forces. Chem Eng Commun 130: 143-166, 1994.
26. Chmelik J: Different elution modes and field programming in gravitational field-flow fractionation; I. A theoretical approach. J Chromatogr A 845: 285-291, 1999.
27. Reschiglian P, Zattoni A, Roda B, Michelini E and Roda A: Field-flow fractionation and biotechnology. Trends Biotechnol 23: 475-483, 2005.
28. Battu S, Cook-Moreau J and Cardot PJP: Sedimentation field-flow fractionation: methodological basis and applications for cell sorting. J Liq Chromatogr R T 25: 2193-2210, 2002.
29. Comte I, Battu S, Mathonnet M, Bessette B, Lalloue F, Cardot P and Ayer-Le Lievre C: Neural stem cell separation from the embryonic avian olfactory epithelium by sedimentation field-flow fractionation. J Chromatogr B 843: 175-182, 2006. (Pubitemid 44636419)
30. Roda A, Parisi D, Guardigli M, Zattoni A and Reschiglian P: Combined approach to the analysis of recombinant protein drugs using hollow-fiber flow field-flow fractionation, mass spectrometry, and chemiluminescence detection. Anal Chem 78: 1085-1092, 2006. (Pubitemid 43271837)
31. Li S, Nickels J and Palmer AF: Liposome-encapsulated actin-hemoglobin (LEAcHb) artificial blood substitutes. Biomaterials 26: 3759-3769, 2005.
32. Andersson CIJ, Arfvidsson C, Kallio PT, Wahlund KG and Buelow L: Enhanced ribosome and tRNA contents in Escherichia coli expressing a truncated Vitreoscilla hemoglobin mutant analyzed by flow field-flow fractionation. Biotechnol Lett 25: 1499-1504, 2003.
33. Andersson M, Fromell K, Gullberg E, Artursson P and Caldwell KD: Characterization of surface-modified nanoparticles for in vivo biointeraction. A sedimentation field flow fractionation study. Anal Chem 77: 5488-5493, 2005.
34. Arfvidsson C and Wahlund Karl G: Time-minimized determination of ribosome and tRNA levels in bacterial cells using flow field-flow fractionation. Anal Biochem 313: 76-85, 2003.
35. Chen Z and Chauhan A: DNA separation by EFFF in a microchannel. J Colloid Interface Sci 285: 834-844, 2005.
36. Farmakis L and Koliadima A: Kinetic study of cell proliferation of Saccharomyces cerevisiae strains by sedimentation/steric field flow fractionation in situ. Biotechnol Prog 21: 971-977, 2005.
37. Garcia MT, Sanz R, Galceran MT and Puignou L: Use of fluorescent probes for determination of yeast cell viability by gravitational field-flow fractionation. Biotechnol Progr 22: 847-852, 2006.
38. Guglielmi L, Battu S, Le Bert M, Faucher JL, Cardot PJP and Denizot Y: Mouse embryonic stem cell sorting for the generation of transgenic mice by sedimentation field-flow fractionation. Anal Chem 76: 1580-1585, 2004.
39. Gascoyne P, Satayavivad J and Ruchirawat M: Microfluidic approaches to malaria detection. Acta Trop 89: 357-369, 2004.
40. Kang D and Moon MH: Hollow fiber flow field-flow fractionation of proteins using a Microbore channel. Anal Chem 77: 4207-4212, 2005.
41. + stem cells by dielectrophoretic field-flow-fractionation. J Hematoth Stem Cell 8: 481-490, 1999.
42. Luo J, Leeman M, Ballagi A, Elfwing A, Su Z, Janson J-C and Wahlund K-G: Size characterization of green fluorescent protein inclusion bodies in E. coli using asymmetrical flow field-flow fractionation-multi-angle light scattering. J Chromatogr A 1120: 158-164, 2006.
43. Lee H, Williams SKR, Wahl KL and Valentine NB: Analysis of whole bacterial cells by flow field-flow fractionation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Chem 75: 2746-2752, 2003.
44. Reschiglian P, Zattoni A, Roda B, Cinque L, Melucci D, Min Byung R and Moon Myeong H: Hyperlayer hollow-fiber flow field-flow fractionation of cells. J Chromatogr A 985: 519-529, 2003.
45. Sanz R, Cardot P, Battu S and Galceran MT: Steric-hyperlayer sedimentation field flow fractionation and flow cytometry analysis Applied to the study of Saccharomyces cerevisiae. Anal Chem 74: 4496-4504, 2002.
46. Yohannes G, Sneck M, Varjo SJO, Jussila M, Wiedmer SK, Kovanen PT, Oeoerni K and Riekkola M-L: Miniaturization of asymmetrical flow field-flow fractionation and application to studies on lipoprotein aggregation and fusion. Anal Biochem 354: 255-265, 2006.
47. Yang J, Huang Y, Wang X-B, Becker FF and Gascoyne PRC: Cell separation on microfabricated electrodes using dielectrophoretic/gravitational field-flow fractionation. Anal Chem 71: 911-918, 1999. (Pubitemid 29107072)
48. Battu S, Elyaman W, Hugon J and Cardot PJP: Cortical cell elution by sedimentation field-flow fractionation. Biochim Biophys Acta 1528: 89-96, 2001.
49. Lautrette C, Cardot PJP, Vermot-desroche C, Wijdenes J, Jauberteau MO and Battu S: SdFFF Purification of immature neural cells from a human tumor neuroblastoma cell line. J Chromatogr B 791: 149-160, 2003.
50. Giraud S, Bessette B, Boda C, Lalloue F, Petit D, Mathonnet M and Jauberteau MO: In vitro apoptotic induction of human glioblastoma cells by Fas ligand plus etoposide and in vivo antitumour activity of combined drugs in xenografted nude rats. Int J Oncol 30: 273-281, 2007.
51. Corbière C, Battu S, Liagre B, Cardot PJP and Beneytout JL: SdFFF monitoring of cellular apoptosis induction by diosgenin and different inducers in the human 1547 osteosarcoma cell line. J Chromatogr B 808: 255-262, 2004. (Pubitemid 38952920)
52. Bégaud-Grimaud G, Battu S, Liagre B, Leger DY, Beneytout JL and Cardot PJP: Pre-apoptotic sub-population cell sorting from diosgenin apoptosis induced 1547 cells by two Sedimentation Field-Flow Fractionation devices. J Chromatogr A 1128: 194-202, 2006.
53. Leger DY, Liagre B, Cardot PJP, Beneytout JL and Battu S: Diosgenin dose-dependent apoptosis and differentiation induction in HEL cell line and SdFFF monitoring. Anal Biochem 335: 267-278, 2004.
54. Leger DY, Battu S, Liagre B, Beneytout JL and Cardot PJP: Megakaryocyte cell sorting from diosgenin-differentiated human erythroleukemia cells by sedimentation field-flow fractionation. Anal Bioche 355: 19-28, 2006. (Pubitemid 44041414)
55. Harold C, Chazala G, Goridisa C and Represa A: NCAM is essential for exonal growth and fasciculation in the hippocampus. Mol Cell Neurosci 8: 323-335, 2002.
56. Ronn LC, Berezin E and Bock E: The neural cell adhesion molecule in synaptic plasticity and ageing. Int J Dev Neurosci 18: 193-199, 2000. (Pubitemid 30129193)
57. Thomas SK, Messam CA, Spengler BA, Biedler JL and Ross RA: Nestin is a potential mediator of malignancy in human neuroblastoma cells. J Biol Chem 279: 27994-27999, 2004.
58. Kim HR, Kim EJ, Yang SH, Jeong ET, Park C, Kim SJ, Youn MJ, So HS and Park R: Combination treatment with arsenic trioxide and sulindac augments their apoptotic potential in lung cancer cells through activation of caspase cascade and mitochondrial dysfunction. Int J Oncol 28: 1401-1408, 2006.
59. Goillot E, Raingeaud J, Ranger A, Tepper RI, Davis RJ, Harlow E and Sanchez I: Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc Natl Acad Sci USA 94: 3302-3307, 1997. (Pubitemid 27157306)
60. Cheema ZF, Wade SB, Sata M, Walsh K, Sohrabji F and Miranda RC: Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-kappaB. J Neurosci Res 19: 1754-1770, 1999. (Pubitemid 29094193)
61. Gallagher HC, Odumeru OA and Regan CM: Regulation of neural cell adhesion molecule polysialylation state by cell-cell contact and protein kinase C delta. J Neurosci Res 61: 636-645, 2000.
62. Bonfanti L: PSA-NCAM in mammalian structural plasticity and neurogenesis. Prog Neurobiol 80: 129-164, 2006.